Physician profile
Daniel Breault
NPI 1699955021
$256,634.90
in general payments reported to CMS, 2019-2025
16 companies · $4,306 in 2025
The $4,306 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $34K · 2021: $40K · 2022: $48K · 2023: $87K · 2024: $29K · 2025: $4,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $105K · Travel and Lodging: $12K · Food and Beverage: $3,022 · Consulting Fee: $650 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $105,300.00 |
| Travel and Lodging | $11,650.29 |
| Food and Beverage | $3,022.06 |
| Consulting Fee | $650.00 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $253,905.39 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Merck Sharp & Dohme LLC | $252.13 | 2019-2020 | |
| Intuitive Surgical, INC. | $236.62 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $120.32 | 2023-2025 | Dupixent |
| Genentech USA, INC. | $119.34 | 2019 | |
| Insmed, INC. | $109.89 | 2025 | Brinsupri, Arikayce |
| Genzyme Corporation | $85.87 | 2019-2025 | |
| Mylan Specialty L.P. | $34.02 | 2021-2023 | Yupelri |
| Baxter Healthcare | $32.81 | 2023 | Hillrom - Life 2000 Ventilation System |
| Boston Scientific Corporation | $30.60 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.86 | 2022-2023 | Spiriva Respimat |
| United Therapeutics Corporation | $22.29 | 2023 | Tyvaso |
| Pulmonx Corporation | $19.57 | 2021 | |
| Philips North America LLC | $19.34 | 2025 | Vest Therapy Und |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $16.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Breault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.